Michael Moradi

Founder at Sensulin

Mike Moradi is a successful entrepreneur, who has founded several nanotech and biotech companies including Charlesson/eyeCRO (ocular pharmaceuticals/CRO), Unidym (carbon nanotubes – acquired by Wisepower for $145M), SWeNT (carbon nanotubes) and NanoSource (acquired by DuPont). He is currently a co-founder and CEO of Sensulin, which is a San Diego based firm developing a next-generation insulin for diabetes.

Categorías de conocimiento

To know more

What if AI spirals out of control? Shahar Avin highlights the existential risks

Can AI spiral out of control and endanger humanity? Shahar Avin explores the most extreme scenarios at the Future Trends Forum

Sovereign AI: the new race for technological autonomy

Jordan Sun warns about the new race for technological sovereignty: without their own AI capabilities, countries and companies will find themselves subordinated. The Future Trends Forum examines the risks and strategies to avoid dependence on the big tech companies

Jeremy Kahn – Beyond the Hype: The Real Trends in Artificial Intelligence

Fortune Magazine’s AI editor cuts through the media noise and points toward a future for artificial intelligence that is more useful, safer, and more human-centered